ETF Managers Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.09M | Buy |
130,676
+84,198
| +181% | +$702K | 0.04% | 206 |
|
|
2022
Q4 | $534K | Sell |
46,478
-8,393
| -15% | -$96.4K | 0.03% | 347 |
|
|
2022
Q3 | $691K | Sell |
54,871
-3,774
| -6% | -$47.5K | 0.02% | 271 |
|
|
2022
Q2 | $634K | Buy |
58,645
+2,631
| +5% | +$28.4K | 0.02% | 319 |
|
|
2022
Q1 | $921K | Buy |
56,014
+1,631
| +3% | +$26.8K | 0.02% | 298 |
|
|
2021
Q4 | $750K | Sell |
54,383
-10,929
| -17% | -$151K | 0.01% | 397 |
|
|
2021
Q3 | $939K | Buy |
65,312
+12,900
| +25% | +$185K | 0.02% | 281 |
|
|
2021
Q2 | $812K | Sell |
52,412
-1,860
| -3% | -$28.8K | 0.01% | 291 |
|
|
2021
Q1 | $542K | Sell |
54,272
-31,608
| -37% | -$316K | 0.01% | 413 |
|
|
2020
Q4 | $644K | Sell |
85,880
-13,069
| -13% | -$98K | 0.01% | 298 |
|
|
2020
Q3 | $379K | Buy |
98,949
+50,274
| +103% | +$193K | 0.01% | 371 |
|
|
2020
Q2 | $242K | Buy |
+48,675
| New | +$242K | 0.01% | 524 |
|